Evidence map›Paper›PMID 29444925›Full record

ArticleCirculation. Cardiovascular quality and outcomes2018

Increasing Incidence and Prevalence of World Health Organization Groups 1 to 4 Pulmonary Hypertension: A Population-Based Cohort Study in Ontario, Canada.

D Thiwanka Wijeratne, Katherine Lajkosz, Susan B Brogly, M Diane Lougheed, Li Jiang, Ahmad Housin, David Barber, Ana Johnson, Katharine M Doliszny, Stephen L Archer

Abstract read
In one paragraph

Article in Circulation. Cardiovascular quality and outcomes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 163 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
163citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

163 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Exercise-based rehabilitation programmes for pulmonary hypertension.The Cochrane database of systematic reviews · 2023
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Evaluation and Management of Sepsis in Pulmonary Hypertension.Journal of intensive care medicine · 2025
    Review
  20. Article

103 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

D Thiwanka WijeratneFrom the Department of Medicine (D.T.W., M.D.L., A.H., D.B., K.M.D., S.L.A.), Institute for Clinical Evaluative Sciences Queen's (D.T.W., K.L., S.B.B., M.D.L., L.J., A.J.), Department of Surgery (S.B.B.), and Department of Public Health Sciences (M.D.L., A.J.), Queen's University, Kingston, ON, Canada.
Katherine LajkoszFrom the Department of Medicine (D.T.W., M.D.L., A.H., D.B., K.M.D., S.L.A.), Institute for Clinical Evaluative Sciences Queen's (D.T.W., K.L., S.B.B., M.D.L., L.J., A.J.), Department of Surgery (S.B.B.), and Department of Public Health Sciences (M.D.L., A.J.), Queen's University, Kingston, ON, Canada.
Susan B BroglyFrom the Department of Medicine (D.T.W., M.D.L., A.H., D.B., K.M.D., S.L.A.), Institute for Clinical Evaluative Sciences Queen's (D.T.W., K.L., S.B.B., M.D.L., L.J., A.J.), Department of Surgery (S.B.B.), and Department of Public Health Sciences (M.D.L., A.J.), Queen's University, Kingston, ON, Canada.
M Diane LougheedFrom the Department of Medicine (D.T.W., M.D.L., A.H., D.B., K.M.D., S.L.A.), Institute for Clinical Evaluative Sciences Queen's (D.T.W., K.L., S.B.B., M.D.L., L.J., A.J.), Department of Surgery (S.B.B.), and Department of Public Health Sciences (M.D.L., A.J.), Queen's University, Kingston, ON, Canada.
Li JiangFrom the Department of Medicine (D.T.W., M.D.L., A.H., D.B., K.M.D., S.L.A.), Institute for Clinical Evaluative Sciences Queen's (D.T.W., K.L., S.B.B., M.D.L., L.J., A.J.), Department of Surgery (S.B.B.), and Department of Public Health Sciences (M.D.L., A.J.), Queen's University, Kingston, ON, Canada.
Ahmad HousinFrom the Department of Medicine (D.T.W., M.D.L., A.H., D.B., K.M.D., S.L.A.), Institute for Clinical Evaluative Sciences Queen's (D.T.W., K.L., S.B.B., M.D.L., L.J., A.J.), Department of Surgery (S.B.B.), and Department of Public Health Sciences (M.D.L., A.J.), Queen's University, Kingston, ON, Canada.
David BarberFrom the Department of Medicine (D.T.W., M.D.L., A.H., D.B., K.M.D., S.L.A.), Institute for Clinical Evaluative Sciences Queen's (D.T.W., K.L., S.B.B., M.D.L., L.J., A.J.), Department of Surgery (S.B.B.), and Department of Public Health Sciences (M.D.L., A.J.), Queen's University, Kingston, ON, Canada.
Ana JohnsonFrom the Department of Medicine (D.T.W., M.D.L., A.H., D.B., K.M.D., S.L.A.), Institute for Clinical Evaluative Sciences Queen's (D.T.W., K.L., S.B.B., M.D.L., L.J., A.J.), Department of Surgery (S.B.B.), and Department of Public Health Sciences (M.D.L., A.J.), Queen's University, Kingston, ON, Canada.
Katharine M DolisznyFrom the Department of Medicine (D.T.W., M.D.L., A.H., D.B., K.M.D., S.L.A.), Institute for Clinical Evaluative Sciences Queen's (D.T.W., K.L., S.B.B., M.D.L., L.J., A.J.), Department of Surgery (S.B.B.), and Department of Public Health Sciences (M.D.L., A.J.), Queen's University, Kingston, ON, Canada.
Stephen L ArcherFrom the Department of Medicine (D.T.W., M.D.L., A.H., D.B., K.M.D., S.L.A.), Institute for Clinical Evaluative Sciences Queen's (D.T.W., K.L., S.B.B., M.D.L., L.J., A.J.), Department of Surgery (S.B.B.), and Department of Public Health Sciences (M.D.L., A.J.), Queen's University, Kingston, ON, Canada. stephen.archer@queensu.ca.

Funding

O2 sensing in the human and rabbit ductus arteriosus.R01HL071115 · NHLBI · UNIVERSITY OF CHICAGO · PI ARCHER, STEPHEN L · 2004 to 2015
$3.1M
The Role of DRP-1 and Mitochondrial Fission in Pulmonary Arterial HypertensionR01HL113003 · NHLBI · QUEEN'S UNIVERSITY AT KINGSTON · PI ARCHER, STEPHEN L · 2013 to 2016
$1.1M
Impaired mitochondrial fusion in pulmonary arterial hypertensionRC1HL099462 · NHLBI · UNIVERSITY OF CHICAGO · PI ARCHER, STEPHEN L · 2009 to 2010
$1.0M
NHLBI NIH HHS R01 HL071115NHLBI NIH HHS R01 HL113003NHLBI NIH HHS RC1 HL099462
6 · The paper itself

Abstract

backgroundThe World Health Organization recognizes 5 groups of pulmonary hypertension (PH), categorized by pathogenesis or comorbidity: 1-pulmonary arterial hypertension 2-left-heart disease, 3-lung disease and hypoxia 4-chronic thromboembolic disease, and 5-miscellaneous. The epidemiology of PH, apart from group 1, is largely unknown. METHODS AND

resultsWe describe incidence, prevalence, comorbidities, mortality and prescribing patterns for groups 1 to 4 PH from 1993 to 2012. Case definitions are based on hospitalizations and emergency department visits, using the Institute for Clinical Evaluative Sciences data, which comprises linked databases of universal coverage health service records for Ontario residents. This cohort included 50 529 patients with PH. The annual incidence of adult PH increased from 2003 to 2012 from 24.1 to 28.7 cases/100 000 population and the annual prevalence from 1993 to 2012 from 99.8 to 127.3 cases/100 000 population, respectively. The most common form of adult PH was group 2, alone (34.2%) or combined with group 3 PH (29.3%). A diagnosis of PH increased the 1-year standardized mortality ratio 7.2-fold. Mortality in adults with PH was 13.0%, 36.4%, and 62.4%, at 30 days, 1 year, and 5 years, respectively. Mortality was highest in groups 2 and 3 and lowest in group 1. PH was present in only 3.6% of people with left heart disease, 0.7% with lung disease, and 1.4% with thromboembolic disease, suggesting that PH is a relatively rare complication of these common diseases. Children (age<16 years) accounted for 3.6% of the cohort. In children group 1 PH was most common (65.2%), and 5-year mortality was lower (21.4%) than in adults. Group 1-specific PH therapies were increasingly prescribed over time and paradoxically were often used in patients who seemed to have group 2, PH based on diagnostic codes indicating left heart disease.

conclusionsThe incidence and prevalence of adult PH are increasing. Groups 2 and 3 are the most common and lethal forms of PH. This study identifies an emerging epidemic of PH that likely has substantial adverse health and economic implications.

Indexed as

AdolescentAdultAgedAged, 80 and overAge DistributionAntihypertensive AgentsChildChild, PreschoolComorbidityDatabases, FactualDrug PrescriptionsFemaleHeart DiseasesHumansHypertension, PulmonaryHypoxiaAntihypertensive Agentscomorbidityheart diseaseshypertension, pulmonaryhypoxiaincidencelung diseasesprevalence

Identifiers

PMID29444925
PMCPMC5819352

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.